Jacobs Levy Equity Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-274,271
Closed -$5.73M 1153
2021
Q1
$5.73M Buy
274,271
+11,902
+5% +$275K 0.04% 397
2020
Q4
$6.01M Sell
262,369
-8,638
-3% -$164K 0.05% 367
2020
Q3
$4.42M Sell
271,007
-11,783
-4% -$213K 0.05% 371
2020
Q2
$3.83M Buy
282,790
+92,758
+49% +$1.08M 0.04% 394
2020
Q1
$2.25M Buy
190,032
+176,362
+1,290% +$3.91M 0.03% 449
2019
Q4
$340K Sell
13,670
-1,260
-8% -$25.5K ﹤0.01% 833
2019
Q3
$254K Buy
+14,930
New +$272K ﹤0.01% 805
2018
Q4
Sell
-68,797
Closed -$1.98M 1103
2018
Q3
$1.98M Buy
68,797
+17,646
+34% +$530K 0.03% 523
2018
Q2
$1.92M Buy
51,151
+5,300
+12% +$208K 0.03% 518
2018
Q1
$1.8M Sell
45,851
-57,871
-56% -$2.11M 0.03% 501
2017
Q4
$3.36M Buy
103,722
+58,260
+128% +$1.75M 0.06% 351
2017
Q3
$1.42M Buy
45,462
+8,950
+25% +$265K 0.03% 516
2017
Q2
$1.02M Sell
36,512
-30,424
-45% -$689K 0.02% 563
2017
Q1
$1.15M Sell
66,936
-53,093
-44% -$744K 0.02% 534
2016
Q4
$1.45M Buy
+120,029
New +$1.55M 0.03% 474

Other funds holding XENT

Jacobs Levy Equity Management's XENT Position: Q2 2021 in Review

Jacobs Levy Equity Management sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 274,271 shares — an estimated $5.73M sold.

Jacobs Levy Equity Management first reported a position in XENT in Q4 2016 and held it in 15 quarters. The position peaked at $6.01M in Q4 2020. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.

  • Jacobs Levy Equity Management reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 274,271 Intersect ENT, Inc shares in Q2 2021, an estimated $5.73M.
  • Jacobs Levy Equity Management first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 15 quarters.
  • Jacobs Levy Equity Management's Intersect ENT, Inc position peaked at $6.01M in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.